uploads///Graph

A Look at Opko Health’s Expense Projections for 2018

By

Nov. 14 2018, Updated 9:00 a.m. ET

Expense projections

In its third-quarter earnings conference call, Opko Health (OPK) forecasted its total costs and expenses for the fourth quarter to fall in the range of $280 million and $290 million. The company has also projected its research and development (or R&D) expenses to fall in the range of $33 million and $38 million in the fourth quarter.

Article continues below advertisement

SG&A and R&D expenses

Wall Street analysts expect Opko Health to report selling, general, and administrative (or SG&A) expenses of $365.60 million in fiscal 2018, which would be a YoY decline of 29.83%. The company is expected to witness SG&A expenses of $437.64 million in fiscal 2019, which would be a YoY rise of 19.70%. Wall Street analysts also expect Opko Health to report SG&A expenses of $491.90 million in fiscal 2020, which would be a YoY rise of 12.40%.

Wall Street analysts have also projected Opko Health’s SG&A expenses to be close to $97.78 million in the fourth quarter, which would be a YoY decline of 21.52%.

Wall Street analysts expect Opko Health to report research and development (or R&D) expenses of $133.16 million in fiscal 2018, which would be a YoY rise of 6.36%. The company is expected to witness R&D expenses of $143.74 million in fiscal 2019, which would be a YoY rise of 7.95%. Wall Street analysts expect Opko Health to report R&D expenses of $159.18 million in fiscal 2020, which would be a YoY rise of 10.74%.

Analysts project Opko Health’s R&D expenses to be close to $36.85 million in the fourth quarter, which would be a YoY rise of 7.75%.

In the next article, we’ll discuss Opko Health’s R&D programs in greater detail.

Advertisement

More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.